{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:57:03Z","timestamp":1768701423428,"version":"3.49.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K500811\/1, MR\/K015451\/1"],"award-info":[{"award-number":["MR\/K500811\/1, MR\/K015451\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["080268"],"award-info":[{"award-number":["080268"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173474","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T14:28:44Z","timestamp":1490970524000},"page":"e0173474","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB)"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9779-9327","authenticated-orcid":true,"given":"Gayathri N.","family":"Sekhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana R.","family":"Georgian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Vizcay-Barrena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Muresan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland A.","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/petr.12441","article-title":"Intravenous pentamidine for Pneumocystis carinii\/jiroveci pneumonia prophylaxis in pediatric transplant patients","volume":"19","author":"A Clark","year":"2015","journal-title":"Pediatr Transplant"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/jpet.108.149872","article-title":"Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: Effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein","volume":"329","author":"L Sanderson","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0020-7519(01)00167-9","article-title":"Transporters in African trypanosomes: role in drug action and resistance","volume":"31","author":"HP de Koning","year":"2001","journal-title":"Int J Parasitol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0001-706X(01)00177-2","article-title":"Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter","volume":"80","author":"HP de Koning","year":"2001","journal-title":"Acta Trop"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/dkt442","article-title":"Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs","volume":"69","author":"JC Munday","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e2475","DOI":"10.1371\/journal.pntd.0002475","article-title":"Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol","volume":"7","author":"FE Graf","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1286-4579(01)01432-0","article-title":"Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle","volume":"3","author":"E Matovu","year":"2001","journal-title":"Microbes Infect"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0014-4894(80)90072-7","article-title":"Trypanosoma brucei: Maintenance of concentrated suspensions of bloodstream trypomastigotes in vitro using continuous dialysis for measurement of endocytosis","volume":"49","author":"AH Fairlamb","year":"1980","journal-title":"Exp Parasitol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/mmi.12979","article-title":"Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein","volume":"96","author":"JC Munday","year":"2015","journal-title":"Mol Microbiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/dmd.108.024083","article-title":"Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters","volume":"37","author":"X Ming","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1471-4159.2010.06801.x","article-title":"Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents","volume":"114","author":"C-J Lin","year":"2010","journal-title":"J Neurochem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10157-011-0460-y","article-title":"Roles of organic anion\/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins","volume":"15","author":"K Hosoya","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bcp.2011.12.032","article-title":"Lamotrigine is a substrate for OCT1 in brain endothelial cells","volume":"83","author":"D Dickens","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","article-title":"The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family","volume":"16","author":"JN Dos Santos Pereira","year":"2014","journal-title":"AAPS J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.actatropica.2004.03.010","article-title":"Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue","volume":"91","author":"LM Sturk","year":"2004","journal-title":"Acta Trop"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/AAC.46.12.3731-3738.2002","article-title":"Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion","volume":"46","author":"M Basselin","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1128\/EC.00152-06","article-title":"Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites","volume":"5","author":"P Leprohon","year":"2006","journal-title":"Eukaryot Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-6851(03)00162-2","article-title":"Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major","volume":"130","author":"AC Coelho","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2008.05730.x","article-title":"The human brain endothelial cell line hCMEC\/D3 as a human blood-brain barrier model for drug transport studies","volume":"107","author":"B Poller","year":"2008","journal-title":"J Neurochem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2011.11.053","article-title":"The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood\u2013brain barrier: Evidence for involvement of breast cancer resistance protein","volume":"1436","author":"CP Watson","year":"2012","journal-title":"Brain Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1038\/cddis.2014.258","article-title":"A\u03b21\u201342 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-\u03baB signaling","volume":"5","author":"R Park","year":"2014","journal-title":"Cell Death Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.freeradbiomed.2003.11.023","article-title":"Flavonoid permeability across an in situ model of the blood-brain barrier","volume":"36","author":"KA Youdim","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"NJ Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/mol.65.3.558","article-title":"Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1","volume":"65","author":"C Chang","year":"2004","journal-title":"Mol Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","article-title":"The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29","volume":"34","author":"JD Young","year":"2013","journal-title":"Mol Aspects Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","article-title":"Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs","volume":"26","author":"P Matsson","year":"2009","journal-title":"Pharm Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1073\/pnas.0408624102","article-title":"Discovery of the ergothioneine transporter","volume":"102","author":"D Gr\u00fcndemann","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","article-title":"Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2","volume":"273","author":"I Tamai","year":"1998","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1021\/jm301302s","article-title":"Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling","volume":"56","author":"MB Wittwer","year":"2013","journal-title":"J Med Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1124\/dmd.115.064824","article-title":"Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors","volume":"43","author":"H Duan","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/00004647-200108000-00005","article-title":"Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2","volume":"21","author":"JY Li","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00424-003-1103-2","article-title":"The equilibrative nucleoside transporter family, SLC29","volume":"447","author":"SA Baldwin","year":"2004","journal-title":"Pfl\u00fcgers Arch Eur J Physiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"T Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF01011956","article-title":"Immunochemistry on ultrathin frozen sections","volume":"12","author":"KT Tokuyasu","year":"1980","journal-title":"Histochem J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e101815","DOI":"10.1371\/journal.pone.0101815","article-title":"Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions","volume":"9","author":"KD Rochfort","year":"2014","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/jcbfm.2009.112","article-title":"Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells","volume":"29","author":"SH Ramirez","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"19781","DOI":"10.1074\/jbc.M310785200","article-title":"Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2","volume":"279","author":"J Xu","year":"2004","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4269\/ajtmh.1996.55.586","article-title":"The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis","volume":"55","author":"F Doua","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/mi.10.5.6","article-title":"Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy","volume":"10","author":"AMS Hartz","year":"2010","journal-title":"Mol Interv"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejps.2008.08.004","article-title":"Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories","volume":"35","author":"R Hayeshi","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1211\/jpp.58.12.0008","article-title":"Haloperidol is an inhibitor but not substrate for MDR1\/P-glycoprotein","volume":"58","author":"K Iwaki","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1021\/jm8003152","article-title":"Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1","volume":"51","author":"G Ahlin","year":"2008","journal-title":"J Med Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1124\/dmd.105.009126","article-title":"NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS","volume":"34","author":"H-J Kang","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(97)01441-5","article-title":"Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1","volume":"419","author":"I Tamai","year":"1997","journal-title":"FEBS Lett"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D","article-title":"Transporter-mediated permeation of drugs across the blood-brain barrier","volume":"89","author":"I Tamai","year":"2000","journal-title":"J Pharm Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/bbrc.1997.7779","article-title":"Evidence for an asymmetrical uptake of L-carnitine in the blood-brain barrier in vitro","volume":"241","author":"JE Mroczkowska","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/clpt.2013.175","article-title":"Profiling solute carrier transporters in the human blood-brain barrier","volume":"94","author":"EG Geier","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/jcbfm.2012.109","article-title":"Transport of biogenic amine neurotransmitters at the mouse blood-retina and blood-brain barriers by uptake1 and uptake2","volume":"32","author":"P Andr\u00e9","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1074\/jbc.M609421200","article-title":"Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family","volume":"282","author":"M Zhou","year":"2007","journal-title":"J Biol Chem"},{"key":"ref50","article-title":"Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins","author":"K-C Wu","year":"2015","journal-title":"J Neurochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1124\/dmd.111.042432","article-title":"Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter","volume":"40","author":"S Itagaki","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1113\/jphysiol.2006.117374","article-title":"Transporters involved in regulation of intracellular pH in primary cultured rat brain endothelial cells","volume":"576","author":"CJ Taylor","year":"2006","journal-title":"J Physiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1471-4159.2005.03312.x","article-title":"Polarized distribution of nucleoside transporters in rat brain endothelial and choroid plexus epithelial cells","volume":"94","author":"ZB Redzic","year":"2005","journal-title":"J Neurochem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0035-9203(84)90289-X","article-title":"Pentamidine-induced diabetes mellitus","volume":"78","author":"TK Jha","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2337\/diab.31.1.40","article-title":"Diabetes mellitus following pentamidine-induced hypoglycemia in humans","volume":"31","author":"P Bouchard","year":"1982","journal-title":"Diabetes"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1371\/journal.pntd.0000333","article-title":"The burden of human African trypanosomiasis","volume":"2","author":"EM F\u00e8vre","year":"2008","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T09:31:31Z","timestamp":1568971891000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173474"}},"subtitle":[],"editor":[{"given":"Hendrik W.","family":"van Veen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173474","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]}}}